Business Wire
09 Oct 2026, 20:30 UTC · 2h ago
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2026 Financial Results
Impact · against what's priced in
CCEL is facing a growth plateau as consolidated revenues remained flat year-over-year at $7.82 million. While the company remains profitable with a net income of $1.27 million, the lack of top-line expansion suggests a ceiling on valuation.
- CCEL−0.10
No priced-in read yet
- In context
Revenues of $7.82 million are essentially flat compared to $7.83 million in the prior year's third quarter, indicating a stagnation in growth despite a quarterly net income of $1.27 million.
Read from the article alone
Search tags
